Latest Distribution Channels News

Argent BioPharma has locked in an A$11 million convertible financing facility to finalize its strategic acquisition of AusCann assets and accelerate its growth plans, including a potential US stock exchange listing.

Camplify Holdings reported a $15.8 million net loss for FY25 amid strategic consolidation and tech integration, while launching its MyWay membership model to drive future profitability.

Bendigo and Adelaide Bank reported steady cash earnings in 1Q26, supported by improved net interest margins and deposit mix, while residential lending contracted amid competitive pressures. Strategic technology rollouts promise growth in the second half.

Associate Global Partners Limited (AGP) reported robust FY25 results, with funds under management climbing to $1.464 billion, driven by stellar investment returns and successful capital raisings. The firm is advancing its distribution reach and launching new products to sustain momentum.

Ovanti Limited has made significant strides in its U.S. buy now, pay later (BNPL) expansion, securing a major partnership with Shift4 Payments and raising $8 million to fuel growth.

Clime Investment Management has bolstered its balance sheet with a $2.3 million placement and launched a strategic product review amid evolving market dynamics and industry consolidation.

Holista Colltech reported improved cash flow management and robust growth in its dietary supplements division for 3QFY25, while navigating ongoing legal challenges with ProImmune.

Nutritional Growth Solutions reported a 13% revenue increase in Q3 FY25, driven by expanded US retail distribution and inventory replenishment. The company raised AU$760k to support growth but faces a tight cash runway, banking on upcoming capital raises and retail momentum.

N1 Holdings reports a steady start to FY26 with a $375,000 net profit and robust cash flow, driven by its SME lending operations and enhanced by AI technology.

Atomo Diagnostics reported strong commercial momentum in Q1 FY26, highlighted by a key FDA submission for its FebriDx test and a successful capital raise of $1.3 million. The company also showcased promising clinical data for its Active Syphilis test and expanded its HIV Self-Test distribution channels.

L1 Group has completed its merger with Platinum Asset Management, forming a $16.9 billion investment powerhouse focused on stabilising funds under management and unlocking significant cost synergies.

Credit Corp Group Limited reported strong earnings growth in 2025, driven by its diversified financial services portfolio and strategic expansion into the UK market, alongside significant advances in AI technology.